Anticarcinogenicity in a long-term rodent bioassay is defined as a statistically significant decrease of a specific tumor type in a dosed group following chemical exposure. About 92% of chemicals tested by the National Toxicology Program prior to 1983 reveal at least one site with a significant (p £ 0.05) tumor rate decrease in one or more tested groups, a result consistent with those of J. K. Haseman and F. M. Johnson (1996, Mutat. Res. 350,131-141) for a database of recently tested chemicals. Detection of tumor decreases in a specific site can be explained not only by biological effects, but also as a result of random variability in the background tumor rates, decreases in body weight, or decreases in survival of treated animals. This paper evaluates the rate of false-positive anticarcinogenic findings due to random effects (variations in tumor rates and the multiple comparisons undertaken in evaluating a bioassay), while a companion paper addresses the influence of weight and survival depression. Monte-Carlo simulation was conducted to assess the contribution of random effects. This contribution was found to be important even when a statistical significance cutoff of p 0 s 0.05 was chosen. If a more stringent statistical criterion was used (p 0 S 0.01 orps 0.005), the proportion of false positive determinations diminishes. The number of anticarcinogens in the database remains substantially higher than predicted by the simulations. An examination of the distribution of all p values (T. Schweder and E. Spj0tvoll, 1982, Biometrika 69, 493-502) also indicates that statistically significant anticarcinogenic responses are found in the database at a higher rate than would result from purely random responses. Finally, the crossspecies prediction of anticarcinogenic responses was examined in a manner similar to a study of cross-species prediction of carcinogenic responses (G. M. Gray et aL, 1995, Reg. ToxicoL Pharmacol. 20, 281-301). The analyses show that anticarcinogenic effects in one rodent species predict well anticarcinogenic effect in another rodent species. It seems Likely that biological factors are involved in anticarcinogenic responses observed in rodent cancer O 1998 Society of Toxicology.
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Long-term rodent bioassays are conducted with the intention of identifying chemicals with the potential to increase cancer rates. Groups of animals are exposed for the most of their life span to the estimated maximum tolerated dose (MTD) of the chemical and usually one additional dose level, often one-half of the MTD. Current bioassays may contain a control group and three to four dose groups to define the dose response. Dose-related increases in site-specific tumor rates are taken as evidence that the compound has carcinogenic potential.
It has long been known, but often dismissed, that statistically significant dose-related decreases for certain tumor sites and types are also found in many long-term rodent bioassays. A well known example is dioxin (Kociba et aL, 1978) . In this study, this phenomenon will be called anticarcinogenicity.
Anticarcinogenicity in the National Toxicology Program (NTP) database has been addressed in several studies. Tested chemicals were often found to decrease the tumor rate in some sites and increase it for others (Weinberg and Storer, 1985; Haseman, 1985; Salsburg, 1983 Salsburg, , 1989 . Salsburg (1983) noted that 20% of early NTP bioassays showed significant reduction in spontaneous tumors with no significant increase in other tumors. Davies and Monro (1994) found a similar frequency of tumor increases and decreases for 37 chemicals studied in the NTP rodent bioassays conducted between 1990 and 1993. Haseman and Johnson (1996) conducted a systematic investigation of the frequency of anticarcinogenic responses based on the data from 218 recent 2-year NTP rodent carcinogenicity studies. About 93% of chemicals were found to show a statistically significant decrease (p 0 ^ 0.05) in tumor incidence in at least one site.
In spite of these findings, it has been regulatory practice to consider only tumor increases when classifying and regulating a substance as a carcinogen. There have been three main arguments against the significance of anticarcinogenic effects in the bioassay. First is that these responses are random and/or result from false-positive detection due to multiple comparisons involved in statistical analysis (Haseman and Johnson, 1996) . Another argument is that decreases in tumor rates are merely a consequence of weight and/or survival decreases in the dosed animals (Haseman, 1983; Albert, 1985; Haseman and Johnson, 1996) . Finally, it has been suggested that these responses are not generalizable and "the fact that a certain inverse relationship between dose and tumor incidence may occur in a single isolated study does not necessarily imply that a general problem exists" (Haseman, 1985) .
The role of random fluctuations of tumor rates in findings of anticarcinogenicity is assessed by means of Monte-Carlo simulations and p value plots (Schweder and Spj0tvoll, 1982) . Rodent bioassays were modeled assuming the absence of chemical exposure. Different levels of statistical significance (0.005 < p 0 < 0.075) for the analyses were assumed. At the higher p values spurious significant anticarcinogenic effects were found to be common. To examine the generalizability of anticarcinogenicity simple concordance analysis was conducted. Anticarcinogenicity was found to predict very well across rodent species. Weight and survival depression is examined in the companion paper.
METHODS

Database.
The carcinogenesis bioassays performed under the NCI/ NTP program are the primary source of data for this analysis. The data are contained in the Carcinogenesis Bioassay Database System (CBDS) and include only early experiments (finished by 1983), at which point the CBDS format was abandoned by NTP. The database consists of bioassays on 18 strains of mice, hamsters, or rats and 7 routes of administration and includes a total of 587 bioassays (some experiments are on mixtures). Most of these bioassays have data for both male and female animals.
CBDS experiments had to meet certain criteria before being analyzed. Each experiment consisted of groups of animals treated by a chemical substance at different doses. Each combination of chemical, species, strain, sex, and route of administration was considered a separate experiment Several criteria were set in this study:
(1) Each experiment had to have at least one control group. (2) Only long-term experiments (exceeding 70 weeks for at least one animal) were included.
(3) All routes of exposure were used in the analysis. (4) Only experiments on mice and rats were considered. All the mouse strains and rat strains were used.
A total of 312 chemicals were found to have experiments for all four sex/ species combinations (male mice (MM), female mice (FM), male rats (MR), and female rats (FR)) satisfying all of the requirements.
The same tumor categorization system that was used in Byrd et aL (1991) and Gray et al. (1995) was implemented in this work. The classification and nomenclature of tumors was not consistent across the years of experiments covered by the CBDS. Therefore several thousand tumor types were reduced into a manageable number of groups. There are a total of 102 categories (sites) which include both tumor types and tumor locations (Table 1) . Among these 102 categories, 66 were classified as malignant primary neoplasms and 36 as benign primary neoplasms. A list of tumor types/sites within each category is available from the authors. Suggested alterations in our classification (J. K. Haseman, personal communication) had little effect on the results of our analyses (data not shown).
Response classification.
Tumor rates in die control groups were used as die background rates. To obtain values for the background rates for each site, the tumor rates in untreated or vehicle control groups were averaged across the database of 312 chemicals. If chemical administration decreases the tumor rate in a dosed group in any of 102 sites, this chemical is classified as an anticarcinogen for the purpose of this paper. Otherwise, the chemical is classified as a non-anticarcinogen. This division is exhaustive; i.e., every one of the 312 compounds falls into one of the two categories. For each sex/species combination, the 312 chemicals can be therefore divided into nonoverlapping groups: anticarcinogens in both sex/species, non-anticarcinogens in both sex/ species, or anticarcinogens only in one sex/species. Similarly, increased tumor rate can be used to classify chemical as a carcinogen or noncarcinogen. Since this classification system looks at site-specific changes, chemicals can simultaneously be carcinogens and anticarcinogens.
The statistical significance for each experiment was calculated by a onesided Fisher's Exact test for dosed and control groups of animals. Relative magnitudes of the first dose administered to the different dosed groups were taken as representative (i.e., if doses changed during the bioassay the beginning dose is used). The numbers of tumors in each group were those at the end of the experiment. The numbers of animals at risk were taken to be either the initial numbers of animals in a group ("unadjusted" analysis) or the number of animals alive when the first animal was found to have a tumor of the category under analysis ("adjusted" analysis). All reported p values for the Fisher Exact test are based on an unadjusted analysis although the conclusion of the paper would not be changed if an adjusted analysis was used. In addition, a mortality-adjusted Cochran-Armitage dose-trend test was performed.
The criteria for judging responses are presented in Table 2 . A positive anticarcinogenic response was defined if either (i) a treated group of animals showed a statistically significant decrease of tumor rates compared to that seen in the control group in at least one site/strain/sex/species at the nominal p value (^o) or two or more groups at twice p 0 or (ii) the decrease was found to be statistically significant at p 0 by the Cochran-Armitage dose-trend test Otherwise the response was classified as negative. Different nominal significance levels (from 0.005 to 0.075) of the one sided Fisher's exact test and dose-trend test were used in the course of the study ( Table 2 ). The examination of carcinogenic responses (Gray et aL, 1995) was identical except that a positive response was an increase in tumor rate. Throughout the analysis a chemical was counted as positive for anticarcinogenicity if it caused a tumor decrease in at least one site of at least one sex of animals.
Monte-Carlo modeling.
It is possible that apparent decreases in tumor rates at some sites could be due to random variation in responses rather than to chemical treatment Likewise, it is also possible that detected increases in tumor rates could also be due to random variation. An analytical estimation of the magnitude of the effect of random variation was made by Haseman and Johnson (1996) although with significant simplification since there are multiple tumor types with different background tumor rates. On the other hand, MonteCarlo simulation can be easily designed to include such differences.
A bioassay with three groups of 50 animals was modeled. One group was modeled as control and the other two were considered to have chemical doses. For all three groups, it was assumed that any changes in tumor rate were due only to random variation with no chemical-related effects. The number of tumors was independently generated for each site in each group according to the spontaneous background rates (Table 1) . No correlation of response between tumor sites (either positive or negative) was built into the model. The variability in response within a group of 50 animals was assumed to be binomially distributed. This binomial distribution is assumed to be reasonable to describe the variability within an experiment (Tarone, 1982; Portier and Hoel, 1983) , although the variability in control tumor rates across experiments is clearly larger than binomial (Haseman et aL, 1994; Haseman, 1995) . The distributions for the background rates were sampled using Random Latin Hypercube sampling methodology. The simulation was done using Analytica (Lumina Decision Systems, Los Altos, CA) software. The number of realizations was chosen depending on the specific objectives of each run and varied from 2000 to 5000. For each realization, all 102 sites were analyzed for statistically significant differences between control and treated groups. For each site, the number of tumors were compared and statistically significant decreases were recorded using the criteria shown in Table 2 .
The model reproduces well the analytical estimations for tumor decreases due to random variations by Haseman and Johnson (1996) if the samep values for statistical tests and the same background tumor rates are assumed.
P-Value plots.
To test the hypothesis that anticarcinogenic responses are due to random response versus an alternative that they are biologically relevant, the cumulative distribution of the observed p values was plotted. Schweder and SpjfMvoll (1982) showed that p values which result from multiple comparison of randomly generated data should tend to be uniformly distributed even if there is a correlational structure that generated them. Therefore, the cumulative distribution function (CDF) for the p values representing random responses should follow a straight line between points (0,0) and (1,1), while an increased number of p values in the low p region would support the alternative hypothesis. To implement this method, a CDF of p values for Fisher Exact and Cochran-Armitage dose-trend tests was constructed using all experiments in the database of 312 chemicals.
Cross-species concordance.
In the context of this paper, concordance refers to the agreement on the statistically significant reduction (or increase) of tumor rates between different species or sexes treated with the same chemical substance. Higher concordance or positive predictive value (PPV) indicates a better chance of observing a response in one group when it is already found in another group. The obvious notion is that a good interspecies concordance in animals may imply a good concordance between animals and humans (Crouch and Wilson, 1979) .
Concordance tables were constructed as in Gray et at. (1995) (Table 3 ). The columns and rows represent the same or different groups of tumor site/type categories in one or another combination of species, strains, routes, and sexes. The numbers in the cells designated A, B, C, and D represent numbers of tested chemical substances that had positive or negative response under a given definition. Perfect concordance would be defined as B = C = 0, meaning that an anticarcinogenic effect found in the row selection always predicts an anticarcinogenic effect in the column selection and not finding an anticarcinogenic effect in the row selection guarantees not finding an anticarcinogenic effect in the column selection. Statistical significance of the observed concordance was tested using the normal approximation of McNemar's test for correlated proportions (Rosner, 1995) using StatView (Abacus Concepts, Berkeley, CA).
RESULTS
Influence of the Cutoff for Statistically Significant Response Classification
The number of tumors in the control groups has an inherent variability due to the stochastic nature of cancer development. Due to this variability, a chemical could be misclassified as a carcinogen/anticarcinogen even if there are no dose-related increase/decreases in tumor rate in exposed groups. For example, if three control groups of animals are taken and watched over 2 years, spontaneous tumors will develop. If the historical spontaneous tumor rate for a specific site is 10%, the resulting number of tumors for this site in three groups of 50 animals might be 8, 5, and 2. In such a case the chemicals would be classified as a statistically significant decrease in tumor rate (p = 0.05 for the Fisher Exact test and p -0.025 for dosetrend test), though all the groups were kept under the same conditions and the only factor operating is random variability.
To estimate the possible influence of random variability, the observed frequencies of anticarcinogenic responses in CBDS database were compared with frequencies of false positive detection due to random variations in the background rate predicted by the Monte-Carlo model. Figures 1 and 2 show the percentage of male mouse (MM), female mouse (FM), male rat (MR), and female rat (FR) anticarcinogens in the CBDS database and those classified by the Monte-Carlo model at different values of p 0 . When criteria for statistical significance were relaxed (p 0 = 0.075) observed anticarcinogenic effects would not be distinguished from those occurring by chance alone. Application of more stringent statistical criteria reduces dramatically the number of false-positive classifications due to random variations, while experimentally observed values decrease less. For p 0 = 0.01 the Monte-Carlo model predicts about 9 and 13% of chemicals for mice and rats, respectively, to be classified as anticarcinogenic in absence of a true effect. CBDS analysis reveals that about 25 and 46% of chemicals administered to mice and rats cause decreases in at least one of reported by Haseman and Johnson (1996) . At this level of statistical significance, the anticarcinogenic effects are difficult to distinguish from random responses. If p 0 = 0.005 is used, the percentage of false-positive classifications drops to 15%, while observed value is about 60%.
The cumulative p plot also indicates that there are nonrandom anticarcinogenic effects. Figure 3 shows the low probability end (p < 0.10) of the p plot and clearly demonstrates that there are more statistically significant responses in the database (solid line) than would be expected by chance (dashed line). Schweder and Spj0tvoll (1982) suggest that the results of this method are independent of any underlying correlation structure in the data.
3.2. Tumor background rate and classification of a chemical. Anticarcinogenic effects can be detected only for tumor types with a rate in control animals high enough that a statistically significant decrease can be observed (Table 1) . There are only a handful of such tumor types for either mice or rats. Figure 4 plots the background tumor rate (averaged over all experiments) against the number of times that a significant decrease was observed for that tumor type in the database at different values of p 0 (0.01, 0.025, and 0.075). Solid lines represent the percentage of chemicals in the database classified as anticarcinogens by the random response Monte-Carlo model. For both mice and rats, there is a strong positive and increasing relationship between the background tumor rate and the likelihood of an anticarcinogenic response for that tumor. A similar result was reported in Haseman and Johnson (1996) . This continuously increasing trend is further evidence that the anticarcinogenic responses in this analysis are not entirely due to random variation. The Monte-Carlo model predicts that random findings of anticarcinogenicity increase with background rate for a while but then plateau. The plateau level depends on the strength of statistical tests used for classification. If a p 0 value of 0.075 was used, most of the observed tumor decreases can be explained by random variability. In contrast, when stringent criteria are used the Monte-Carlo model predictions of anticarcinogenic responses are at a level well below those experimentally observed.
Concordance Across Species
Prediction of an anticarcinogenic response to a chemical from one rodent species to the other was examined using the data in the CBDS and compared with the predictions that would be expected due to chance alone. Table 4 shows the concordance table for anticarcinogenic responses derived from CBDS using p 0 = 0.01. The PPV from mice to rats is 75%. This means that if an anticarcinogenic response due to chemical exposure is observed in a mouse, then in 75% of cases an anticarcinogenic response is also found in the rat for that same chemical. The mouse to rat PPV for anticarcinogens is higher than that for carcinogens (86% versus 76% for p 0 = 0.025 (Gray et al, 1995) ). The rat to mouse PPV for anticarcinogenicity is 56% (for p 0 = 0.025), lower than the PPV for carcinogenic response (71%). Figure 5 compares the cross-species concordance that would be found if only random effects occurred with that observed in CBDS. Using a criterion for statistical significance of p 0 = 0.01, a considerably higher concordance was found in the CBDS than would be predicted if random variation were the sole cause (Mice-Rats PPV = 75% vs 27%; Rat-Mice PPV = 46% vs 17%). This difference increases as more strict levels of statistical significance are used. The concordance differs between species because the background rates of different tumor types varies.
Concordance of Carcinogenicity and Anticarcinogenicity
If anticarcinogenic effects exist, the interpretation of the bioassay would be complicated when a chemical causes both increases and decreases in tumor rates. Table 5 is a matrix of the number of chemicals causing increases (rows) or decreases (columns) in tumor rates in mice and rats. The same value of p 0 = 0.01 was used for both carcinogenic and anticarcinogenic chemical classifications. The column and row headings are response in mice/rats where + indicates the presence of the effect and -its absence in each species. It was found that a significant fraction of the database (28/312) is chemicals that are classified as both carcinogens and anticarcinogens for both mice and rats. There are a few chemicals which cause solely carcinogenic (20/312) or anticarcinogenic effects (13/312) in both rats and mice. Only 32/312 (about 10.2%) of chemicals tested show no effect on tumor rates in either rats or mice. At p 0 = 0.01 the concordance of both anticarcinogenicity and carcinogenicity between the rodent species is quite statistically significant (p £ 0.01) by McNemar's test. Interestingly, at/J 0 = 0.025 only the anticarcinogenicity concordance is significant (data not shown).
DISCUSSION
Site-specific decreases in tumor rates are very common in long-term rodent bioassays, as evidenced by the examination of the database of 312 studies initiated by NTP program prior to 1981. This phenomenon cannot be fully explained by random variability in the background tumor rate or false positive classification due to multiple comparisons.
The Monte-Carlo model can be used as a tool in quantitative evaluation of the contribution of random fluctuations in overall effect for a specific experimental design. The most important assumption in the model is binomial variability around the mean background tumor rate for each tumor type. This assumption has frequently been used by others {e.g., Tarone, 1982; Portier and Hoel, 1983) . If variability is smaller the random effect will be smaller, if variability is larger then the random effect will be larger. Another key assumption is lack of correlation, either positive (a decrease in one site is correlated with a decrease in another) or negative (a decrease in one site is correlated with an increase in another). The cumulative p plot indicates the presence of nonrandom anticarcinogenic effects and results of this method were shown to be independent of any underlying correlation structure in the data (Schweder and Spj0tvoll, 1982) . Although correlation between certain tumor types is known to occur {e.g., Young and Gries, 1984) , there is too little information to make any quantitative statement about the relationships between all of the 102 tumor types in our analysis. This should be an area for further study.
The p value of the statistical test being used in an analysis can be thought of as an indicator of the random variability that an analyst is willing to accept. Interpretation problems arise when the false positive rate is substantially different from the nominal p value. The false positive rate is analysis specific and depends on the nominal p values chosen but also depends on the number and type of comparisons conducted. In this analysis the statistical definition of anticarcinogenicity is clearly an important factor for chemical classification. The model reveals high sensitivity to the stringency of the statistical tests used. Therefore, it may be reasonable to use more stringent p values (0.01 or 0.005) to classify a chemical as an anticarcinogen. The Monte-Carlo analysis indicates that if these p values are used, the false positive rate is sufficiently small that random variation apparently plays a small role in the classification of chemicals as having anticarcinogenic effects.
As a rule, the tumor types that decrease are different between mice and rats (just as tumor sites that increase are usually different between mice and rats). Of course anticarcinogenic effects can be detected only in that small subset of tumor types with sufficiently high background rates. Table 6 summarizes the tumor types most often found to demonstrate anticarcinogenic effects in mice and rats and the average background tumor rate in those sites. However, other sites are also found to have tumor rate decreases in specific experiments.
When carcinogenic effects are evaluated by the National Toxicology Program, statistical significance is only one factor weighed by a panel of expert peer reviewers. For this reason there is some difference between chemicals judged to have some or clear evidence of carcinogenicity by the NTP and those with statistically significant increases in the rate of one or more tumor type. Perhaps future studies will include judgments about the evidence for anticarcinogenicity found in each bioassay. The long-term bioassays are quite insensitive for detecting anticarcinogenicity because so few tumor types have background rates high enough to decrease significantly. Nevertheless, the likelihood of detecting an anticarcinogenic response appears to increase proportionally with background tumor rate, while a solely random effect is predicted to plateau. This factor contributes to the conclusion that many chemicals tested in CBDS are having a real anticarcinogenic effect on some tumor types.
The high predictive value across species, much higher than would be expected if effects were random, is a clue that the chemicals are having an effect general to both species. The concordance of carcinogenic response across species has been suggested as evidence that chemicals cause real increases in tumor rates. Given similar rates of cross-species concordance for anticarcinogenic effects it seems logical to assume that these responses are real, too.
CONCLUSION
In examining the carcinogenic and anticarcinogenic responses in rodent bioassays it is interesting to note the large number of entries in the cell for chemicals causing both carcinogenic and anticarcinogenic effects in each species. Of those that can be classified to be carcinogenic in both species about half are also anticarcinogenic in both species. It seems that these chemicals have the ability to increase tumors in some sites and decrease tumors in other sites. However, it may be that the high doses used in the rodent bioassay so perturb the animals' physiology that the responses that occur, both positive and negative, have little meaning for lower doses. Future work will focus on ways to integrate increases and decreases into an overall judgment of carcinogenic potential.
